International Journal of Head and Neck Surgery

Register      Login

VOLUME 3 , ISSUE 1 ( January-April, 2012 ) > List of Articles

RESEARCH ARTICLE

Correlation of Parotid Gland Function in Head and Neck Cancer Patients treated with Intensity-modulated Radiotherapy

Sonal Vahanwala, Sukhjinder Kaur Khosa, Sandeep S Pagare

Citation Information : Vahanwala S, Khosa SK, Pagare SS. Correlation of Parotid Gland Function in Head and Neck Cancer Patients treated with Intensity-modulated Radiotherapy. Int J Head Neck Surg 2012; 3 (1):1-4.

DOI: 10.5005/jp-journals-10001-1079

Published Online: 01-04-2012

Copyright Statement:  Copyright © 2012; The Author(s).


Abstract

How to cite this article

Khosa SK, Vahanwala S, Pagare SS. Correlation of Parotid Gland Function in Head and Neck Cancer Patients treated with Intensity-modulated Radiotherapy. Int J Head and Neck Surg 2012;3(1):1-4.


PDF Share
  1. Intensity modulated radiation therapy (IMRT): A new promising technology in radiation oncology. The Oncologist, December 1999;4(6): 433-42.
  2. Isolation and identification of Candida from the oral cavity. Oral Dis 2000;6;3-11.
  3. Manifestations and treatment of xerostomia and associated oral effects secondary to head and neck radiation therapy. J Am Dent Assoc 1997;128:1128-33.
  4. Xerstomia: Aetiology and management in cancer patients. Support Care Cancer 1998;6:348-55.
  5. Intensity-modulated radiation therapy (IMRT): A clinical perspective. Introduction. Semin Radiat Oncol 2002;12:197-98.
  6. A quantitative test for xerostomia. The Saxon test, an oral equivalent of the Schirmer test. Arthritis Rheum 1985;28:1128-32.
  7. Dose, volume and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999;45:577-87.
  8. Evaluation of parotid gland function following intensity-modulated radiotherapy for head and neck cancer. Cancer Res Treat 2006;38(2):84-91.
  9. Intensity-modulated radiation therapy (IMRT): The most important advance in radiotherapy since the linear accelerator. The British Journal of Radiology 2003;76:673.
  10. Subcutaneous administration of amifostine during fractionated radiotherapy: A randomized phase II study. J Clin Oncol 2000 June; 18(11):2226-33.
  11. Sialogoguerelated radioprotection of salivary gland function: The degranulation concept revisited. Radiat Res Sep 1997;148(3): 240-47.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.